Regulatory Updates

Latest News

FDA Approves Biweekly Dosing of Tecvayli for Multiple Myeloma
FDA Approves Biweekly Dosing of Tecvayli for Multiple Myeloma

February 21st 2024

Patients with multiple myeloma who switched from weekly to biweekly dosing of Tecvayli were able to maintain their response with fewer infections.

 LASZLO-stock.adobe.com
FDA Sets Review Date for Linvoseltamab for Advanced Multiple Myeloma

February 21st 2024

 iDoPixBox-stock.adobe.com
FDA Sets Date for First-in-Class Lung Cancer Therapy

February 19th 2024

FDA Approves Amtagvi, the First TIL Therapy for a Solid Tumor
FDA Approves Amtagvi, the First TIL Therapy for a Solid Tumor

February 19th 2024

FDA Sets Date for Full Approval, Broader Indication for Elevidys
FDA Sets Date for Full Approval, Broader Indication for Elevidys

February 16th 2024

Latest CME Events & Activities

More News

© 2024 MJH Life Sciences

All rights reserved.